Orion
73.05 EUR
-0.41 %
14,364 following
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orion
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,051.0 | 1,078.1 | 1,041.1 | 1,340.6 | 1,189.6 | 1,542.4 | 1,889.5 | 2,061.2 | 2,300.0 | 2,454.1 | 2,849.5 |
| growth-% | 2.6 % | -3.4 % | 28.8 % | -11.3 % | 29.7 % | 22.5 % | 9.1 % | 11.6 % | 6.7 % | 16.1 % | |
| EBITDA | 308.9 | 336.5 | 289.0 | 486.6 | 326.4 | 629.6 | 689.5 | 751.3 | 878.1 | 943.6 | 1,053.7 |
| EBIT (adj.) | 252.8 | 280.1 | 243.3 | 439.6 | 274.9 | 416.5 | 631.6 | 699.9 | 793.5 | 858.9 | 968.8 |
| EBIT | 252.8 | 280.1 | 243.3 | 439.6 | 274.9 | 416.5 | 631.6 | 699.9 | 793.5 | 858.9 | 968.8 |
| Profit before taxes | 250.8 | 278.3 | 242.3 | 440.3 | 271.9 | 413.0 | 627.7 | 695.9 | 792.9 | 859.9 | 970.4 |
| Net income | 200.4 | 219.9 | 193.8 | 349.5 | 216.8 | 329.7 | 500.2 | 548.9 | 650.2 | 705.1 | 795.7 |
| EPS (adj.) | 1.57 | 1.38 | 2.49 | 1.54 | 2.35 | 3.54 | 3.89 | 4.61 | 5.00 | 5.64 | |
| growth-% | -11.9 % | 80.3 % | -38.0 % | 52.1 % | 51.0 % | 9.7 % | 18.4 % | 8.4 % | 12.9 % | ||
| Dividend | 0.00 | 1.50 | 1.50 | 1.60 | 1.62 | 1.65 | 1.72 | 1.78 | 1.85 | 1.91 | 1.97 |
| Dividend ratio | 95.8 % | 108.7 % | 64.3 % | 105.0 % | 70.2 % | 48.6 % | 45.9 % | 40.1 % | 38.2 % | 34.9 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA-% | 29.4 % | 31.2 % | 27.8 % | 36.3 % | 27.4 % | 40.8 % | 36.5 % | 36.5 % | 38.2 % | 38.4 % | 37.0 % |
| EBIT-% (adj.) | 24.1 % | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 27.0 % | 33.4 % | 34.0 % | 34.5 % | 35.0 % | 34.0 % |
| EBIT-% | 24.1 % | 26.0 % | 23.4 % | 32.8 % | 23.1 % | 27.0 % | 33.4 % | 34.0 % | 34.5 % | 35.0 % | 34.0 % |
| ROE | 29.1 % | 26.8 % | 43.1 % | 24.1 % | 34.8 % | 43.7 % | 38.2 % | 36.3 % | 31.9 % | 29.5 % | |
| ROI | 34.4 % | 29.5 % | 45.6 % | 24.9 % | 34.4 % | 43.3 % | 42.6 % | 43.1 % | 38.9 % | 36.0 % |